Researchers Identify Genetic Regulators of Blood Density
The study validates 30 genomic regions that influence red blood cell traits, mapping functional links to GWAS variants.
Updated on Oct. 21, 2026 in Life Sciences
Researchers have identified 17 genes and 13 non-coding genomic sequences that regulate red blood cell density. This discovery, published in a peer-reviewed research article, characterizes the functional impact of variants previously linked to blood traits.
Why it matters
Understanding the precise genetic and non-coding regulation of blood cell traits is essential for interpreting genome-wide association study data. This research provides a functional roadmap for linking thousands of known genetic variants to specific cellular phenotypes.
Researchers perturbed 556 candidate sequences across 2,114 GWAS variants to isolate regulatory effects. Among the findings, deletions in the OXSR1 gene specifically increased cell density, while a non-coding sequence near rs13255015 showed dual regulation of ZFAT and SLC4A1 expression.
The details
The team utilized pooled CRISPR screens, a method for testing gene function by systematically disabling specific DNA segments, within an erythroid cell line—a precursor cell type that develops into red blood cells. By combining these perturbations with RNA-sequencing, researchers mapped how non-coding sequences influence gene expression in cis, affecting the neighboring gene, and in trans, affecting distal genes. This process clarifies how non-coding segments control cellular traits, distinguishing them from the 1,000 loci previously correlated with blood traits through observational data alone.
Timeline
October 21, 2026: The research findings were published in a peer-reviewed article.
The Tech Race
This study updates the map of the human genome by moving beyond the historical catalog of 1,000 loci associated with red blood cell traits. By isolating specific functional genes and non-coding regions, it shifts the competitive research focus from simple trait mapping to causal biological mechanisms.
This research provides a fundamental map for future diagnostic developments rather than an immediate clinical test or therapeutic for the public. It serves as a necessary benchmark for clinical researchers working to interpret individual genetic risks related to blood cell health.
The takeaway
The study demonstrates that non-coding sequences play a critical, previously unmapped role in regulating red blood cell traits. Scientists should now monitor further studies examining how the identified ZFAT and SLC4A1 regulatory pathways influence broader cardiovascular health outcomes.
Further reading
For broader context on genomic discovery, visit the Life Sciences section.
More information
View the complete peer-reviewed research article for a detailed breakdown of the experimental methodology.
Source note: This article includes information reported by Nature.
